Real-world experience of long-term albumin treatment in patients with cirrhosis and ascites
Event: Real ANSWER Webinar Date: February 7, 2024 Location: Virtual
Speaker: Dr. Paolo Caraceni (Bologna, Italy)
Professor of Internal Medicine, Department of Medical and Surgical Science, Alma Mater Studiorum University of Bologna, Italy
Head of the Internal Medicine and Alcohol and Liver Disease Unit, IRCCS Azienda Ospedaliera-Universitaria of Bologna, Italy
| Time | Topic | |
|---|---|---|
| 10:00h | Welcome and introduction | |
| 10:05h | Beginning of the lecture (pre-recorded video) | |
| 10:25h | Q&As live session | |
| 10:45h | End of Webinar | |
| 15:00h | Welcome and introduction | |
| 15:05h | Beginning of the lecture (pre-recorded video) | |
| 15:25h | Q&As live session | |
| 15:45h | End of Webinar |
Disclaimer: This webinar does not intend to promote the use or prescription of Long Term Albumin in countries in which this indication is not approved. Long Term Albumin is off label in the US.
GNL-ABP-2400001
How I Treat CIDP
Dr. Muley will present one of his cases of a 45-year-old man who reported progressive arm and leg weakness. Dr. Muley will walk through his decision making process for diagnosis and treatment including consideration of new modalities for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).
Albumin and microcirculation in sepsis and septic shock.
Speaker: Prof. Bertrand Guidet (Paris, France)
Sepsis is a life-threatening condition in response to dysregulated host response to infection, resulting in cardiovascular compromise and potential multi-organ failure (1). Macrocirculatory alterations and microcirculation dysfunction are frequent and participate concurrently in the pathophysiology of organ failure. Several studies have described the role of endothelial dysfunction, including damage to the glycocalyx, in the microcirculatory blood flow deterioration in sepsis (2).
Albumin is physiologically bound within the glycocalyx, thus contributing to its stability. Overall, there is growing evidence that albumin may preserve glycocalyx integrity and the microcirculation in the context of acute damage, both in experimental models and in critically ill patients (3,4).
| Time | Topic | |
|---|---|---|
| 10:00 | Welcome and introduction (pre-recorded video) – Cristina Fuster (Medical Affairs Manager, Grifols) | |
| 10:05 | Beginning of the lecture (pre-recorded video) | |
| 10:25 | Q&As live session | |
| 10:45 | End of Webinar | |
| 15:00 | Welcome and introduction (pre-recorded video) – Cristina Fuster (Medical Affairs Manager, Grifols) | |
| 15:05 | Beginning of the lecture (pre-recorded video) | |
| 15:25 | Q&As live session | |
| 15:45 | End of Webinar |
(1) Evans L, et al. Intensive Care Med. 2021;47(11):1181-1247.
(2) Uchimido R, et al. Crit Care. 2019;23(1):16.
(3) Aldecoa C, et al. Ann Intensive Care. 2020;10(1):85.
(4) Hariri G, et al. Int Care Med. 2018;44(5):669-671.
Never miss another live webinar!
Sign-up and get notified when our next live webinar is happening.
Don’t worry, we will never spam you.